Abilify Gambling Injury Lawsuits Will Move Forward to Preliminary Trials

Plaintiffs have successfully defeated Otsuka Pharmaceutical and Bristol-Meyers Squibb’s motion to dismiss multidistrict litigation relating to alleged compulsive behavior side effects of the widely prescribed drug Abilify. As reported by Law360, U.S. District Judge M. Casey Rodgers issued a decision on March 16th finding that “consumers have shown their … evidence is sound and reliable

2018-03-19T22:51:27+00:00March 19th, 2018|Prescription Drug Injuries|

Title